Literature DB >> 3722512

Pityriasis lichenoides in children: therapeutic response to erythromycin.

A P Truhan, A A Hebert, N B Esterly.   

Abstract

Fifteen of twenty-two children with pityriasis lichenoides were treated with oral erythromycin. Eleven (73%) had a remission, usually within 2 months. Two others showed partial improvement, and two were unimproved. Seven of the children who experienced a remission were off erythromycin and free of lesions after 2 to 5 months of therapy. A trial of erythromycin as described herein should be considered in children with pityriasis lichenoides before other, possibly more toxic, measures are instituted.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722512     DOI: 10.1016/s0190-9622(86)70144-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Febrile ulceronecrotic Mucha-Habermann disease.

Authors:  F-X Lejuste; C Michaux; C Lehners; N Calteux
Journal:  BMJ Case Rep       Date:  2013-10-14

Review 2.  Macrolides in chronic inflammatory skin disorders.

Authors:  Abdullateef A Alzolibani; Khaled Zedan
Journal:  Mediators Inflamm       Date:  2012-05-17       Impact factor: 4.711

3.  Pityriasis lichenoides et varioliformis acuta: case report and review of the literature.

Authors:  Neide Pereira; Ana Brinca; Maria Manuel Brites; Maria José Julião; Oscar Tellechea; Margarida Gonçalo
Journal:  Case Rep Dermatol       Date:  2012-03-23

4.  Erythromycin as a Safe and Effective Treatment Option for Erythema Annulare Centrifugum.

Authors:  Fu-Chen Chuang; Shang-Hong Lin; Wei-Ming Wu
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

Review 5.  Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in Dermatology.

Authors:  Swetalina Pradhan; Bhushan Madke; Poonam Kabra; Adarsh Lata Singh
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.